EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, vol.22, no.5, pp.372-376, 2001 (SCI-Expanded)
Purpose of investigation: The aim of our study was to assess whether serum levels of serum insulin-like growth factor-I (IGF-I) could be used for the follow-up of the patients with epithelial ovarian cancer and to identify whether it was superior to serum CA 125.